IL1B and neoplasm: As vitamin D3 acts as an inhibitor of IL1-β release, its activity was prevented by exogenous IL1β and was dependent on the expression of VDR on macrophages (Fig. 4A, Fig. 4B) and not on tumor cells (data not shown).